Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Ubiquitin Signaling in Regulation of the Start of the Cell Cycle

Ubiquitin signaling in cell cycle control and tumorigenesis

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Ubiquitin ligases: cell-cycle control and cancer

How phosphorylation by PINK1 remodels the ubiquitin system, a perspective from structure and dynamics.

Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells

Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling

Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5

K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle

Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis

Cellular signals integrate cell cycle and metabolic control in cancer

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression

Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases

The role of ubiquitination in health and disease

Ubiquitination in the regulation of inflammatory cell death and cancer

E3 Ubiquitin Ligases: Key Regulators of TGF Signaling in Cancer Progression

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.